(PRVA) Privia Health - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74276R1023

PRVA: Technology, Population Health, Administrative Support, ACOs, Networks

Privia Health Group, Inc. (NASDAQ:PRVA) is a national physician-enablement company headquartered in Arlington, Virginia, specializing in enhancing healthcare delivery through technology, population health tools, and value-based care solutions. Founded in 2007, the company partners with physician practices, health plans, and health systems to optimize clinical and financial outcomes. Its offerings include a technology platform streamlining provider workflows, a management services organization reducing administrative burdens, and a single-TIN medical group fostering negotiating power and clinical alignment. Privia also operates accountable care organizations (ACOs) focused on improving patient quality metrics and reducing inappropriate utilization. Additionally, it provides a network for purchasers and payers to connect providers with new patient populations and facilitate custom contracting arrangements. The companys approach emphasizes enabling providers to focus on patient care while navigating the complexities of value-based care.

Over the next three months, Privia Health Group is expected to maintain its current trajectory, supported by its strategic position in the value-based care market. The stock is likely to experience moderate volatility, with potential upside driven by continued execution of its physician-enablement model and expansion of its ACO network. Based on the provided data, the SMA 20 crossing above the SMA 50 suggests short-term bullish momentum, while the SMA 200 indicates longer-term strength. The ATR of 0.90 signals manageable volatility. Fundamentally, the companys forward P/E of 45.87 reflects expectations of future growth, though the current P/E of 219.91 highlights elevated valuations. Market participants may closely monitor the companys ability to maintain profitability and scale its operations in a competitive healthcare landscape.

Additional Sources for PRVA Stock

PRVA Stock Overview

Market Cap in USD 2,829m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Services
IPO / Inception 2021-04-28

PRVA Stock Ratings

Growth Rating 3.31
Fundamental 21.2
Dividend Rating 0.0
Rel. Strength 38.6
Analysts 4.57/5
Fair Price Momentum 23.42 USD
Fair Price DCF 15.47 USD

PRVA Dividends

No Dividends Paid

PRVA Growth Ratios

Growth Correlation 3m -52.2%
Growth Correlation 12m 85.8%
Growth Correlation 5y -65.9%
CAGR 5y 2.16%
CAGR/Max DD 5y 0.03
Sharpe Ratio 12m 0.69
Alpha 23.73
Beta 0.775
Volatility 37.05%
Current Volume 1443.6k
Average Volume 20d 571k
What is the price of PRVA stocks?
As of May 09, 2025, the stock is trading at USD 25.07 with a total of 1,443,631 shares traded.
Over the past week, the price has changed by +9.48%, over one month by +15.32%, over three months by +5.20% and over the past year by +32.93%.
Is Privia Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Privia Health is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 21.18 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRVA as of May 2025 is 23.42. This means that PRVA is currently overvalued and has a potential downside of -6.58%.
Is PRVA a buy, sell or hold?
Privia Health has received a consensus analysts rating of 4.57. Therefor, it is recommend to buy PRVA.
  • Strong Buy: 14
  • Buy: 5
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for PRVA stock price target?
According to ValueRays Forecast Model, PRVA Privia Health will be worth about 26.3 in May 2026. The stock is currently trading at 25.07. This means that the stock has a potential upside of +4.75%.
Issuer Forecast Upside
Wallstreet Target Price 29.3 16.9%
Analysts Target Price 29.3 16.9%
ValueRay Target Price 26.3 4.7%